Skip to Main Content

INFORMATION FOR

    Soki Kashima, MD, PhD

    Postdoctoral Associate
    DownloadHi-Res Photo

    About

    Titles

    Postdoctoral Associate

    Biography

    Soki Kashima is a urologic surgeon, and a physician-scientist at Akita University School of Medicine in Japan. He graduated from Akita University, and then he received his PhD in Medicine from Akita University Graduate School of Medicine, completing his doctoral research in the Laboratory of Immunology at Kyoto University under the mentorship of Prof. Hiroshi Kawamoto. In doctoral research, he studied the efficacy of antigen-specific T cell therapies derived from iPS cells for renal cell carcinoma, using both in vitro and in vivo (orthotopic xenograft models in mice) models. After his PhD, he has continued his research and clinical work as Assistant Professor at Kyoto University and Akita University with mentorship from Prof. Osamu Ogawa, Prof. Takashi Kobayashi and Prof. Tomonori Habuchi. He has an extensive research skillset in analyzing immune cell function and phenotype, measuring cytotoxicity of T cells, and in patient-derived xenograft mouse models. In the BraunLab, he is using immunogenomic and functional approaches to dissect the tumor microenvironment and understand mechanisms of immunotherapy efficacy in renal cell carcinoma.

    Departments & Organizations

    Education & Training

    Assistant Professor
    Graduate School of Medicine, Akita University (2022)
    Clinical Fellowship
    Kyoto University / Akita University (2022)
    PhD
    Akita University (2020)
    Assistant Professor
    Graduate School of Medicine, Kyoto University (2020)
    Resident
    Akita University (2017)
    General Exchange Special Research Student
    Institute for Life and Medical Sciences, Kyoto University (2015)
    MD
    Akita University (2011)

    Research

    Research at a Glance

    Yale Co-Authors

    Frequent collaborators of Soki Kashima's published research.

    Publications

    Featured Publications

    2024

    • Prognostic impact of histological discordance between transurethral resection and radical cystectomy.
      Matsuda A, Taoka R, Miki J, Saito R, Fukuokaya W, Hatakeyama S, Kawahara T, Fujii Y, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Iio H, Yasue K, Abe T, Nakanishi S, Matsumura M, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Matsui Y, Japanese Urological Oncology Group. Prognostic impact of histological discordance between transurethral resection and radical cystectomy. BJU Int 2024 PMID: 38344879, DOI: 10.1111/bju.16296.
      Peer-Reviewed Original Research

    2023

    Academic Achievements & Community Involvement

    • honor

      Merit Award

    • honor

      Future of Science Fund scholarship

    • honor

      Postdoctoral and Clinical Fellowship Award

    • honor

      14th Young Researcher Promotion Grant

    • honor

      The 106th Annual Meeting Award

    Get In Touch

    Contacts

    Locations

    • Center of Molecular and Cellular Oncology

      Lab

      300 George Street, Fl 6th Floor, Ste Suite 6109

      New Haven, CT 06511